Navigation Links
Lilly Receives Award From National Medical Association
Date:7/27/2009

INDIANAPOLIS, July 27 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) was given the Corporate Circle Partners award by the National Medical Association (NMA) at their 113th annual conference and scientific assembly over the weekend in Las Vegas.

Lilly has developed a long-standing, productive partnership with the NMA to advance specific issues facing patients and to address healthcare disparities.

"We can't do this alone," said Mohammad N. Akhter, M.D., MPH, executive director, National Medical Association. "As strong as the NMA and Lilly are separately, together we have greater impact in this country for the betterment of all of us."

Signature NMA programs such as the Global Health Initiative and policy shaping consensus panel are examples of the collaboration with Lilly. In addition, the NMA continues to actively participate in a Lilly diabetes initiative that serves to empower African Americans to overcome key barriers to success in living with diabetes, the Fearless African-Americans Connected and Empowered (F.A.C.E.) campaign.

Further, in an effort to increase the diversity of its clinical trials, Lilly also utilizes physicians involved in the NMA's Project Impact as clinical trial investigators. Project Impact encourages greater participation of African Americans in all aspects of biomedical research and clinical trials, including supporting African-American physicians in the process.

"We are honored and humbled by this noteworthy acknowledgment," said Jack Harris, M.D., vice president of the U.S. medical division at Lilly. "Lilly shares a common interest with the NMA - to come together to share knowledge that goes beyond medicine to improve individual patient outcomes."

National Medical Association

Founded in 1895, the National Medical Association is the nation's oldest and largest medical association representing the interests of more than 30,000 African-American physicians and their patients. The NMA has repeatedly advocated for policies that would assure equitable and quality health care for all people.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
2. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
3. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
4. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
5. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
6. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
7. Lilly Declares Third-Quarter Dividend
8. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
9. Eli Lilly and Company Announces New Drug Discovery Initiative
10. NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
11. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... ... leading digital and print media enterprise focused on cancer patients, cancer centers and ... released a special 12-part educational video series, “No Ifs, Ands, or Butts,” that ...
(Date:3/22/2017)... ... 22, 2017 , ... The Rett Syndrome Research Trust (RSRT) ... that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in ... females. Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... to its Department of Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular ... surgery. She is board-certified in both Orthopedics and Hand Surgery. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Norwich, NY (PRWEB) , ... March 22, 2017 , ... ... to communities in the greater Nassau County region, is embarking on a combined charity ... breast cancer. , For the last 25 years, the Great Neck Breast Cancer ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... TapImmune, Inc. (NASDAQ: TPIV), ... of innovative peptide and gene-based immunotherapeutics for the ... that it will participate in two upcoming Investor ... Wilson , Chairman and CEO of TapImmune, will ... pipeline and partnering opportunities for its proprietary PolyStart ...
(Date:3/22/2017)... , March 22, 2017 Hologic, Inc. ... has completed the acquisition of Cynosure, Inc., a leader ... share in cash. "We are pleased to ... working with Michael Davin and the entire ... large, rapidly growing medical aesthetics market," said Steve ...
(Date:3/22/2017)... 2017 TFS is pleased to announce the ... Tumaian , two global executive positions in Medical Affairs and Clinical ... Leadership Team and will report to Dr. Montse Barceló , ... ... 10 years of medical and scientific expertise gained across leading biopharmaceutical ...
Breaking Medicine Technology: